Treatment of chronic hepatitis C in children with pegylated interferon and ribavirin : the impact of dose ORIGINAL ARTICLE
![SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients](https://minio.scielo.br/documentstore/1678-4391/QYd4dfhPQqHxbJYjws7sMqw/85308efb6d05af4c3a3c2b5488d91d5a506d6b06.gif)
SciELO - Brasil - Treatment of chronic hepatitis C in treatment-naïve patients Treatment of chronic hepatitis C in treatment-naïve patients
![Pegylated interferon-α2b and ribavirin decrease claudin-1 and E-cadherin expression in HepG2 and Huh-7.5 cells | Annals of Hepatology Pegylated interferon-α2b and ribavirin decrease claudin-1 and E-cadherin expression in HepG2 and Huh-7.5 cells | Annals of Hepatology](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//16652681/0000001200000004/v1_201906141018/S1665268119313468/v1_201906141018/en/main.assets/gr4.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNeKOJqKH5+Za6P+RA5Vq9Dloi2SjpU87RVqB5pdExBba3/KeVEoWrN/INBR1hyeUSChREjkHslqd8Qt3WrBSUT9cHewJmG5dYRLLF6/XghJew1Go3rJ60kHMUf36eonWrVyOtaocB2VUVKo/QZJZjwgx80XVpbTqlx+72Aiwigq2GGR2PSFke0Gucl6a6uDIOIiQ2tbRT8jKwN303stHiOhTiS+z8TeomLIDbP9EFUNMuST5j/nPep9tBk/2zd0SdM=)
Pegylated interferon-α2b and ribavirin decrease claudin-1 and E-cadherin expression in HepG2 and Huh-7.5 cells | Annals of Hepatology
![Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis](https://www.spandidos-publications.com/article_images/etm/16/2/etm-16-02-0971-g02.jpg)
Psychiatric side effects of pegylated interferon‑α and ribavirin therapy in Iranian patients with chronic hepatitis C: A meta‑analysis
Full article: Dyspnoea in patients with chronic hepatitis C treated with pegylated interferon and ribavirin
![Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis](https://www.frontiersin.org/files/Articles/702929/frph-03-702929-HTML/image_m/frph-03-702929-g001.jpg)
Frontiers | Maternal and Fetal Outcomes After Interferon Exposure During Pregnancy: A Systematic Review With Meta-Analysis
The use of interferon alfa, peginterferon alfa and ribavirin for the treatment of chronic hepatitis C
![Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download](https://cyberleninka.org/viewer_images/415062/f/1.png)
Short versus standard treatment with Pegylated interferon alfa-2a plus ribavirin in patients with hepatitis C virus genotype 2 or 3: the CLEO trial. – topic of research paper in Clinical medicine. Download
![PDF] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. | Semantic Scholar PDF] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9ced2b2becd29b4342952a49f534b2f9f0e08131/3-Figure1-1.png)
PDF] Pegylated interferon alfa-2b vs standard interferon alfa-2b, plus ribavirin, for chronic hepatitis C in HIV-infected patients: a randomized controlled trial. | Semantic Scholar
![Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrgastro.2011.21/MediaObjects/41575_2011_Article_BFnrgastro201121_Fig5_HTML.jpg)
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
Full article: Pegylated interferon 2a and 2b in combination with ribavirin for the treatment of chronic hepatitis C in HIV infected patients
![Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial - The Lancet Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial - The Lancet](https://www.thelancet.com/cms/attachment/2000977426/2003577226/gr1.gif)
Pegylated interferon alfa-2b alone or in combination with lamivudine for HBeAg-positive chronic hepatitis B: a randomised trial - The Lancet
![Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fnrgastro.2011.21/MediaObjects/41575_2011_Article_BFnrgastro201121_Fig1_HTML.jpg)
Management of adverse effects of Peg-IFN and ribavirin therapy for hepatitis C | Nature Reviews Gastroenterology & Hepatology
![JCM | Free Full-Text | Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals JCM | Free Full-Text | Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals](https://www.mdpi.com/jcm/jcm-12-02195/article_deploy/html/images/jcm-12-02195-g001-550.jpg)
JCM | Free Full-Text | Outcomes and Follow-Up after Hepatitis C Eradication with Direct-Acting Antivirals
![PDF) Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan | Kow-tong Chen - Academia.edu PDF) Long-term outcomes and risk factors of thyroid dysfunction during pegylated interferon and ribavirin treatment in patients with chronic hepatitis C infection in Taiwan | Kow-tong Chen - Academia.edu](https://0.academia-photos.com/attachment_thumbnails/80229518/mini_magick20220205-32277-1pzibsh.png?1644049410)